Completed
Sorafenib in Elderly mRCC
NCT01728948
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Many Locations, China
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
153 public trials
10 recruiting studies
Carcinoma, Renal Cell trial results
NCT01521715
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Urolog. Klinik im Waldkrankenhaus St. Marien, Friedrich-Alexander-Universität Erlangen, Germany
- Universitätsklinikum Essen, Klinik f. Urologie Essen, Germany
- Med. Klinik II, Johann-Wolfgang-Goethe-Universität Frankfurt, Germany
- Medizinisches Versorgungszentrum (MVZ) Osthessen GmbH Fulda, Germany
NCT00537056
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Completed
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
NCT00835978
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- East Bay Medical Oncology/Hematology Medical Associates Inc. Antioch, California, United States
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States
- Diablo Valley Oncology and Hematology Medical Group Inc Pleasant Hill, California, United States
Completed
Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer
NCT01064310
- Conditions
- Adenocarcinoma, Behavior, Carcinoma, +18 more
- Locations
-
- Novartis Investigative Site Helsinki, Finland
- Novartis Investigative Site Joensuu, Finland
- Novartis Investigative Site Lahti, Finland
- Novartis Investigative Site Seinäjoki, Finland
NCT01557127
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Many Locations, Poland
NCT00244764
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- GSK Investigational Site Duarte, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Orange, California, United States
- GSK Investigational Site San Francisco, California, United States
NCT00256880
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site Durham, North Carolina, United States
- GSK Investigational Site Philadelphia, Pennsylvania, United States
NCT02334709
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Dept. of Radiotherapy, Ghent University Hospital Ghent, Oost-Vlaanderen, Belgium
NCT01367457
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- Complexo Hospitalario Universitario A Coruña A Coruña, Spain
- Hospital de La Santa Creu I Sant Pau Barcelona, Spain
- Hospital Vall D'Hebron Barcelona, Spain
- Hospital del Mar Barcelona, Spain